20 Nov Prescription patterns of ranitidine in Canada (Q20-12)
Posted at 13:35h
in
Prescription patterns of ranitidine in Canada (Q20-12)
Q20-12
Overview
What are the objectives?
- The objectives are to characterize the use of dispensed H2RAs in Canada by describing demographic and clinical characteristics of users and prescribers and by quantifying rates of use and population exposures.
Manuscripts
Levy AR, Stock D, Paterson JM, Tamim H, Chateau D, Quail J, Ronksley PE, Carney G, Reynier P, Targownik L, for the Canadian Network for Observational Drug Effect Studies (CNODES). Prescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial cross-sectional analysis. CMAJ Open. 2023;11(6):E1033-E1040.